New onset idiosyncratic liver enzyme elevations with biological therapy in inflammatory bowel disease
Author:
Affiliation:
1. Gastroenterology Unit; Massachusetts General Hospital; Boston MA USA
2. Harvard Medical School; Boston MA USA
3. Department of Pathology; Massachusetts General Hospital; Boston MA USA
Funder
National Institutes of Health
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13159/fullpdf
Reference31 articles.
1. Review article: infliximab therapy for inflammatory bowel disease-seven years on;Rutgeerts;Aliment Pharmacol Ther,2006
2. Surgical management of ulcerative colitis in the era of biologicals;Devaraj;Inflamm Bowel Dis,2015
3. Infliximab for induction and maintenance therapy for ulcerative colitis;Rutgeerts;N Engl J Med,2005
4. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis;Ford;Am J Gastroenterol,2011
5. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial;Hanauer;Lancet,2002
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Investigation of abnormal liver blood tests in patients with inflammatory bowel disease;Frontline Gastroenterology;2024-09-02
2. Low ALT Is Associated with IBD and Disease Activity: Results from a Nationwide Study;Journal of Clinical Medicine;2024-03-24
3. Prognostic factors for liver, blood and kidney adverse events from glucocorticoid sparing immune-suppressing drugs in immune-mediated inflammatory diseases: a prognostic systematic review;RMD Open;2024-01
4. Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies;British Journal of Dermatology;2023-11-01
5. Certolizumab-induced liver injury: as assessed for causality by the updated RUCAM;BMJ Case Reports;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3